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Phosphorylation of mouse epidermal proteins by en-
dogenous protein kinases and production of arachidonic 
acid are processes stimulated by the tumor promoter 12-
0-tetradecanoylphorbol-13-acetate. In mouse epidermal 
homogenates, each process, as well as production of 
diacylglycerol (the physiologic activator of protein ki-
nase C), was inhibited by bromophenacyl bromide at 
concentrations equivalent to those that inhibit tumor 
promotion. These results lend support to the hypothesis 
that tumor promotion in mouse skin may be mediated by 
activation of protein kinase C. 
Squamou ce ll ca rcinomas are elici ted in mouse ep idermis by 
a two-stage ini t iation-promot ion protocol [1] which consists of 
o n e application of a subt hreshold dose of carcinogen followed 
by repeated applications of a tumor promoter such as 12-0-
tetradecanoylphorbo l-13-acetate (TPA). Neither stage alone 
produces tumors. 
Topical application of bromophenacy l bromide (BPB) re-
duces t he incidence and frequency of TPA-promoted tumo rs 
[2 ,3 ]. Since TPA -treated cells release a rachidonic acid (AA) [4] 
a nd BPB a lkylates hist idine in the active site of pancreatic 
phospholipase A~ (PLA2 ) [ 5], one of seve ral lipases t hat release 
AA inhibi t ion of tu mor development by BPB has been mte r-
preted to support t he hypothesis t hat AA metabolites mediate 
tumor promotion. However, unlike TPA, other hyperplasJ-
ogenic compounds wh ich also stimulate AA release do not 
p ro m ote tumors [6]. Therefore, AA metaboli tes may not be 
primary mediators of tumor promotion [ 4,6]. 
Recent reports indicate t hat t he phospholipid-dependent, 
Ca2 + -activated phosphotra nsfe rase, protein kinase C [7- 9], is 
activated by TPA [J0- 12] and is t he receptor of TPA (11- 14). 
This ev idence suggests t hat protein kinase C may mediate t he 
pleiotropic cellular responses to TPA by phosphorylating, and 
t hus stimulating or inactivating, specific enzymes and other 
substra te proteins. Since mouse ep idermis is a classic system 
fo r studies of tumor promotion, we are investigating protein 
kinase C activ ity in this t issue. 
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Protein kinase C from brain is reversibly activated when it 
forms a complex with Ca2+, anionic phospholipid, and TPA or 
diacylglycerol (DG) [7 ,10]. Anionic detergent is used to disso-
ciate the complex formed in particulate homogenate [14] and 
appears to reactivate the complexed enzyme [15,16]. DG, t he 
endogenous activator of protein kinase C [10], is released from 
phosphatidylinositol (PI) when phospholipase C (PLC) hydro-
lyzes t he glyce rol-phosphoinositol bond. 
Since the functiona l integrity of protein kinase C requires 
reduced, in tact sulfuydryl groups [8,11 ,12] and since the spec-
trum of enzymes inhibited by BPB includes those with essential 
-SH [17,18], as well as histidine groups [5] and Ca2+ as 
cofacto r [19], it seemed plausible t hat BPB would also inhibi t 
protein kinase C. Here, we present evidence t hat BPB inhibited 
TPA-stimulated phosphorylation of 4 epidermis proteins. BPB 
also inhibited DG production and activity of addi t iona l epider-
mis protein kinases. 
MATERIALS AND METHODS 
The sources of mate ria ls used were as fo llows: Female Ha/ ICR mice 
from Harlan Sprague· Dawley; phosphat.idylethanolamine (PE), L-a·l-
palmitoyl,[l -" C]-2-arachidonyl PE (sp act 32.1 Ci/ mmol), and ['y -32P] 
ATP from New England Nuclear; phosphatidylcholine (PC), [~ - 3Hj 
arachidonyl PC (sp act 34 Ci/mmol) from Amersham; AA, PI, PE, PC, 
phosphatidylserine (PS), phosphatidic acid, lysoPE, lysoPC, sphingo· 
myelin, and Redicoat-2D t hin -laye r chromatography (TLC) plates from 
Supelco; dia rachidonyl glyce rol (DA) from NuChek; silica gel G TLC 
plates from Analtech; Liquiscint from National Diagostics, TPA from 
Dr. Peter Borchert, Chemical Carcinogenesis. BPB was a gift from 
Fluka A.G. Dr. Ahern of New England Nuclear kindly provided [~-'HJ 
arachidonyl PI (sp act 20 Ci/ mmol). All other chem icals were obtained 
from S igma. 
Preparation of Epidermal Hom.ogenates 
Twenty -four hours after their back skins were shaved, mice were 
killed by cervical dislocation and immersed in liquid N2 for 35 s. The 
epidermis scraped from each back skin was kept in liquid N2 until it 
was added to 2 ml 0.15 M NaCl and Polytron homogenized at -20"C, 
full speed for 60 s. Gauze-filtered homogenate, post 10,000 g 30-min 
and post 100,000 g 60-min fractions were prepared at 5"C and stored 
at -so·c until use. 
Protein. Kinase Assay 
The incubation medium, tota l volume 250 J.ll, conta ined 20 mM 
HEPES/ NaOH, pH 7.5, 2.5 roM CaC12, 1.3 mM MgCl2, 0.1 % taurodeox-
ycholate (TDOC), 10 J.lg PI , 15 !J.M ATP, 2.5 nmol h-32P]ATP (2 .1 J.I.Ci) 
and 20 1-' g protein [20] from the 10,000 g 30-min supernatant that had 
been preexposed to 5 JLl acetone, wi t h or without BPB, for 30 min a t 
37"C. When added, PI in CHC13:CH,.OH (3:1) , TPA in acetone, and 
0.2 1-'g DA in CHCb:CH30 H (3:1) were first placed at the bottom of 
each assay tube and dried under a stream of N2 before the addition of 
the other chemicals. Phosphorylation was begun by the addi t ion of 
homogenate supernatant and stopped afte r 5 min with 1/3 volume STOP: 
20% glycero l, 4% sodium dodecyl sulfate (SDS) , 10% 2-mercaptoetha-
nol in 0.25 M Tris-HCl, pH 6.8. 
SDS-polyacrylamide gel electrophoresis (PAGE) [21] was performed 
on a Hoefer s lab gel apparatus. T he gels were dried on a Hoefer s lab 
dryer at 60"C. Autoradiograms were prepared with Kodak X-Omat AR-
5 film exposed 4 days at -80"C. 
Phospholipase Assays 
Radiolabe led phospholipid, -25,000 dpm , was placed in polypropyl -
ene test tubes and dried under N2• Incubation medium, fina l volume 
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250 11!, contained 0.2 M HEPES/NaOH, pH 7.0, 6 mM CaCI2, 0.1 % 
TDOC. Hydrolys is was begun by addit ion of 20 11g homogenate protein 
]19] which had been preincubated with 5 11! acetone, with or without 
BPB, for 30 min at 37' C. After 60-min incubation in a Dubnoff shaking 
water bath at 37'C, the reaction was stopped by the addition of 50 11l 
1.0 N HCI. Neutra l lipids and fatty ac ids were extracted 3 times with 
hexame. Total lipids were extracted with CHC13/CH30H [22]. All 
extrac ts were stored under N 2 at -20'C un t il analyzed by TLC. Exper-
imental points were obtained in duplicate or triplicate, and experiments 
were repeated 1-5 times. 
Lipid standards were added to t he lipid extracts before t he extracts 
were spotted onto TLC plates under N 2 in a Desaga spotting chamber 
and developed in a Brinkman chamber. AA, 1,2-DG, and 1,3-DG were 
developed on silica ge l G plates with petroleum elher:diethyl 
ether:acetic acid (80:20:1) [23 ]. These lipids, as well as PC, lysoPC, PE, 
lysoPE, and monoacylglycerol were also isolated by two-step TLC on 
silica gel G plates 124]. The plates were first developed in 
CHC13:CH30H:H20 (65:35:.5) to 7 em above the origin, dried under N2 
for 30 min, and fully developed with heptane:diethyl ether:formic acid 
(90:60:4). Two-dimensional TLC on Redicoat-2D plates was used to 
sepa rate PE, P I, PS, PC, lysoPC, sphingomyelin, and phosphatidic 
acid. The first dimension was developed with CHCb:CH30 H:28% 
NH,OH (6.5:35:5), dried for 1 h u11der N2, and developed in the second 
dimension with CHCb:acetone:CH30H:glacial acetic acid:H 20 
(3:4:1 :1:0.5) [25] . Developed lipids were visualized with 12 vapor and 
the outlined spots were scraped in to 1 ml distilled H 20. After 30 min , 
9 ml Liquiscint was added to the scrapings, and samples were cou nted 
in a Packard Tricarb 460 C/D scintillation cou nter. Total lipid recovery 
averaged 80%. 
RESULTS 
The 10,000 g supernatant epidermal proteins which were 
phosphorylated in the presence of Ca2+, Mg2+ , and detergent 
displayed a high level of protein kinase activity (Fig 1, lanes 1 
and 2). Addition of either of the cofactors, TPA or DG, inten-
sified phosphorylation of 4 proteins having M, = 20K, 13K, 
lOK, and < lOK, (lanes 3-6). Phosphorylation was more intense 
in response to 25 ng TPA (lanes 3 and 4) than to 200 ng DG 
(lanes 5 and 6). Since TPA and DG are known to activate only 
protein kinase C, the 4 phosphorylated proteins appear to be 
specific epidermal substrates for protein kinase C. Addition of 
phospholipid, a cofactor for protein kinase C, did not in tensify 
phosphorylation or revea l additional substrates (lanes 2, 4, and 
6). This lack of response to exogenous phospholipid suggests 
that a saturating level of endogenous phospholipid is present 
in the 10,000 g homogenate supernatant, as has been noted by 
others [26]. 
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FIG 1. TPA-stimulated phosphorylation of epidermal proteins and 
inhibition of phosphorylation by BPB. Lane I, no addition; lane 2, 10 
l'g PI ; lane 3, 2.5 ng TPA; lane 4, 25 ng TPA, 10 11g PI; lane 5, 0.2 11g 
DA; lane 6, 0.2 11g DA, 10 11g PI; lane 7, 28 11g BPB, 10 ,.,g PI, 25 ng 
TPA. All lanes contained 2.5 mM Ca2+ and 0.1% TDOC. Standards 
were: myos in , 200 kD; phosphorylase b, 92 kD; bovine serum albumin, 
66 kD; ovalbumin, 45 kD; carbonic an hydrase, 31 kD; lysozyme, 21.5 
kD; cytochrome c, 1.3.4 kD. 
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TABLE I. Comparison of the specific activities of three epidermis 
homogenate fractions toward individual fH}a.rachidonic acid-labeled 
phospholipid substrates 
Cell Homogenate Fractions 
Substrate pH 10,000 X g 100,000 X g Whole Supernatant Supernatant 
PI 7.0 31.65 ± 0.40 38.0 ± 1.59 42.69 ± 3.22 8.5 0.00 ± 0.00 0.53 ± 0.34 2.78 ± 1.76 
PE 7.0 1951 ± 369 1860 ± 611 1906 ± 196 8.5 179±108 305 ± 153 345 ±175 
PC 7.0 1.67 ± 0.94 0.43 ± 0.40 1.34 ± 0.43 8.5 4.45 ± 1.04 1.10 ± 1.10 1.74 ± 0.20 
Data expressed as mean fmol/10 11g protein/60 min ± SE of 2-4 
experiments. 
TABLE II. Relative percentages of radiolabeled arachidonic acid (AA) 
and diacylglycerol (DC) released by 20 11g epidermi.s homogenate 
fraction, protein after 60-min incubation at 37°C 
Substrate Homogenate 
Percent of total product (AA + DG) 
pH fraction AA DG 
PI Whole" 7.0 0.0 ± 0.0 100.0 ± 0.0 lOOK gb 7.0 9.5 ± 3.1 90.5 ± 3.1 
PE Whole 7.0 95.9 ± 2.9 4.1 ± 2.9 100Kg 7.0 89.8 ± 6.0 10.2 ± 6.0 
PC Whole 7.0 100.0 ± 0.0 0.0 ± 0.0 lOOK g 7.0 89.8 ± 3.8 10.2 ± 3.8 
PC Whole 8.5 100.0 ± 0.0 0.0 ± 0.0 IOOKg 8.5 91.1 ± 8.9 8.9 ± 8.9 
" Whole extract. 
b 100,000 g supernatant. 
Data expressed as mean ± SE of 2-5 experiments. 
activity. Homogenate protein (250 J.lg in 100 J.Ll) was preexposed 
to BPB (139 J.Lg) for 30 min before 20-J.Ll portions were removed 
for gel electrophoresis. This concentration of BPB sharply 
reduced all phosphorylation, including that specifically acti-
vated by TP A. Inhibition of protein kinase activity by BPB 
was dose-related and detectable at levels as low as 2.78 J.lg.BPB/ 
250 J.lg epidermal protein (data not shown). Since we routinely 
obtain -1 mg protein/epidermis, the amounts of BPB that 
inhibited phosphorylation fell well below the range (0.25- 2.78 
mg/mouse) reported to reduce by 50% the incidence and fre-
quency ofTPA-promoted tumors in mice [2,3]. 
Individual phospholipids, PC, PE, and PI, radiolabeled in 
the {3 position with [aH]AA, were used to characterize the 
epidermal phospholipases which also proved to be inhibited by 
BPB. Analysis of enzyme activity over the pH range of 4.0- 9.0 
showed that the optimum for PI and PE hydrolysis was pH 7.0. 
Hydrolysis of PC was so limited in this assay system that 
differences in enzyme activity between pH 7.0 and pH 8.5 were 
not significant. The phospholipases that hydrolyze PI and PE 
were apparently concentrated in the cytosolic or 100,000 g 
fraction, si nce removal of t he particulate fraction from the 
whole homogenate did not reduce hydrolytic actvity (Table I). 
PC lipases appeared to be more evenly distributed between 
cytosolic and particulate fractions (Table 1). The major lipid 
released from PI was DG (Table II). This finding suggests that 
in mouse epidermis only phospholipase C hydrolyzes PI, the 
sole phospholipid source of DG . The major lipid product of PE 
and PC was AA (Table II) . Since AA can be produced either 
by PLA~ attack on the {3 ester bond or by sequential actions of 
PLA1 on the a ester bond and lysophospholipase on the {3 bond, 
these experiments do not determine conclusively whether one 
or both PLAs hydrolyze PE or PC. Although no radiolabeled 
lysoPE or lysoPC was found after 1-h incubation, shorter 
incubation periods may reveal the transient presence of t hese 
products of PLA1. 
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FIG 2. Inhibition by BPB of hydrolysis of PI (ll--ll), PE 
(......__.),and PC (0-----0) by epidermis phospholipases. Values ex-
pressed as mean ± SE of 2-6 separate experiments. 
Exposure to varying concentrations ofBPB for 30 min caused 
a concentration-dependent inhibition of the cytosolic PLA and 
PLC activities (Fig 2). Half-maximal inhibition occurred in the 
range of 1- 5 x 10-• M BPB (27.8-139.0 J.Lg/mg protein), con-
centrations well below those found to inhibit tumor promotion 
in vivo [2,3). 
DISCUSSION 
One approach to the elucidation of the biochemical path-
way(s) that mediate tumor promotion is identification of com-
pounds which both block tumor promotion and interfere with 
the activity of specific enzymes. This approach was used re-
cently to demonstrate that the inhibitor of tumor promotion, 
quercetin, inhibits protein kinase C [27]. Thus far, inhibitors 
of specific enzymes that also inhibit tumor promotion have not 
been found. Quercetin [27] and BPB [5,15- 17] are nonspecific 
enzyme inhibitors. Indeed, Hofmann et a! [17] showed that 
BPB prevented protein phosphorylation in platelets. Here we 
show that BPB inhibits protein phosphorylation in epidermis. 
Since BPB inhibits the specific phosphorylation stimulated by 
TP A, it is likely that BPB inhibits protein kinase C. Many 
phenomena inhibited by BPB, including tumor promotion, 
heretofore thought to be mediated by another enzyme inhibited 
by BPB, PLA2, may t herefore, in view of the accumulating 
evidence, be mediated by protein kinase C. Inhibition of phos-
pholipase C by BPB, which we demonstrate, also involves 
protein kinase C since this phospholipase releases DG, the 
physiologic activator of protein kinase C. 
The identity of and relevance to tumor promotion of the 4 
low-molecular-weight proteins whose phosphorylation was seen 
to be stimulated by TPA and inhibited by BPB remain to be 
investigated. Candidate substrate proteins include histones, M, 
= 12-20K. Histones are known substrates of protein kinase C 
[8- 14] . Histone phosphorylation fo llowing treatment with TPA 
coincides with DNA replication and mitosis in mouse epidermis 
[28,29). A 15K protein substrate of protein kinase C is reported 
to be present in several t issues [30,31]. In view of observations 
that TPA activates PLA2 [4] but not PLC [10]. that thrombin 
activation of PLA2 requires ATP [32]. and that PLA2 is acti-
vated by a phosphorylation process at pH 7.5 [33], it is tempting 
t o speculate that the 13K substrate identified in this report 
may be PLA2. A molecular weight of -13K is assigned to several 
PLA2 s (34). That a cAMP-dependent protein kinase is not 
involved in AA release is substantiated by reports that PLA2 is 
inhibited by cAMP [35,36] and not affected by calmodulin [37). 
Phospholipase activities in epidermis from species other t han 
mouse have been described [28- 41]. In those studies PC was 
the only substrate used. The pH optima were variously reported 
as pH 6.1-7.4 [39], pH 7.5 (40], pH 8.3 [38], and one each at 
pH 4.5 and 8.5 [41]. One report located the PLA activity in the 
105,000 g particulate fraction [ 40], and another in the 100,000 
g supernatant [41]. In our system the level of PC hydrolysis 
was too low to permit us to distinguish among these choices. 
We found that mouse epidermal PLAs more actively hydrolyzed 
PE and PI than PC. Both the PE-specific PLA and t he PI-
specific PLC were maximally active at pH 7.0 and were located 
in the cytosol. These properties of mouse epidermal PLA are 
closely similar to those described for purified rat spleen PLA2 (42). The properties of mouse epidermal PLC in our crude 
homogenate fractions are similar to those ascribed to sheep 
tissue PLCs which have been purified and extensively charac-
terized [ 43] . 
BPB inhibited hydrolysis of PI, PE, and PC by mouse 
epidermal phospholipases. Production of AA by the predomi-
nantly PE-specific, cytosolic PLA and production of DG by the 
PI-specific, cytosolic PLC were reduced approximately 50% by 
the BPB/protein concentration found to inhibit tumor pro-
motion 50%. 
The findings t hat equivalent amounts of the alkylating agent 
BPB inhibit both tumor promotion and TPA-stimulated pro-
tein phosphorylation in mouse epidermis are consistent with 
the hypothesis [10-14] that the TPA-activated protein kinase 
C is a primary mediator of tumor promotion. 
We thank Lori Batta for her technical assistance, Dr. S. Belman for 
use of his facilities, and Maureen Freitag for preparing the manuscript. 
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